Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage forms and human plasma

Chemical and Pharmaceutical Bulletin

Volumn 55, Issue 12, 2007, Pages 1662-1670

  El Enany, Nahed ^a   El Sherbiny, Dina ^b   Belal, Fathalla ^a  

^a Mansoura University 35516   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

2,4 dinitro fluorobenzene; 4 chloro 7 nitrobenzo 2 oxa 1,3 diazole; Desloratadine; HPLC; Spectrofluorometry; Spectrophotometry

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; 4 CHLORO 7 NITROBENZOFURAZAN; ACETONITRILE; AZITHROMYCIN; BORIC ACID; CIMETIDINE; DESLORATADINE; ERYTHROMYCIN; FEXOFENADINE; FLUOXETINE; KETOCONAZOLE;

ABSORPTION SPECTROSCOPY; ACCURACY; ARTICLE; CONTROLLED STUDY; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG STRUCTURE; FEMALE; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PH; SEPARATION TECHNIQUE; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY; TABLET FORMULATION; ULTRAVIOLET RADIATION; VALIDATION STUDY;

CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINITROFLUOROBENZENE; HISTAMINE H1 ANTAGONISTS; HUMANS; HYDROGEN-ION CONCENTRATION; LORATADINE; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS;

EID: 36849012916     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.55.1662     Document Type: Article

References (38)

1. Kleemann A., Engels J., "Encyclopedia of Pharmaceutical Substances," 4th ed., pdf, 2000. http://rapidshare.de/Files/26793581/
2. Graul A., Leeson P. A., Castaner J., Drug Future, 25, 339-346 (2000).
3. Handley D. A., McCulloug J. R., Fang Y., Ann. Allergy Asthma Immunol., 79, 164-169 (1997).
4. Johnson R., Christensen J., Lin C., J. Chromatogr. B., 657, 125-131 (1994).
5. Zhang D., Blume H., Pharmazie, 49, 736-739 (1994).
6. Yin O. O. P., Shi X., Chow M. S. S., J. Chromatogr. B., 796, 165-172 (2004).
7. Liu L., Qi M., Wang P., Li H., J. Pharm. Biomed. Anal., 34, 1013-1019 (2004).
8. Yang L., Clement R. P., Kantesaria B., Reyderman L., Beaudry F., Grandmaison C., Di Donato L., Masse R., Rudewicz P. J., J. Chromatogr. B., 792, 229-240 (2003).
9. Sutherland F. C. W., De Jager A. D., Badenhorst D., Scanes T., Hundt H. K. L., Swart K. J., Hundt A. F., J. Chromatogr. A, 914, 37-43 (2001).
10. Shen J. X., Wang H., Tadros S., Hayes R. N., J. Pharm. Biomed. Anal., 40, 689-706 (2006).
11. Zhang Y. F., Chen X. Y., Zhong D. F., Dong Y. M., Acta Pharmacol. Sin., 24, 715-718 (2003).
12. Kubacak P., Mikus P., Valaskova I., Havranck E., Ceska Slov. Farm., 54, 266-269 (2005).
13. Qi M., Wang P., Geng Y., J. Pharm. Biomed. Anal., 38, 355-359 (2005).
14. Pesez M., Bartos J., "Colorimetric and Fluorometric Analysis of Organic Compounds and Drugs," Marcel Dekker Inc., New York, 1974, pp. 128-132, 170.
15. El-Emam A. A., Hansen S. H., Moustafa M. A., El-Ashry S. M., El-Sherbiny D. T., J. Pharm. Biomed. Anal., 34, 35-44 (2004).
16. El-Enany N., J. AOAC Int., 86, 209-214 (2003).
17. Ulu S. T., J. Chromatogr. B, 834, 62-67 (2006).
18. Walash M. I., Belal F., Ibrahim F., Hefnawy M., Eid M., J. AOAC Int., 85, 1316-1323 (2002).
19. Al-Ghanam S. M., Belal F., J. AOAC Int., 85, 817-823 (2002).
20. El-Shabrawy Y., Belal F., Sharaf El-Din M., Shalan Sh., Il Farmaco, 58, 1033-1038 (2003).
21. Darwish I. A., Anal. Chim. Acta, 551, 222-231 (2005).
22. Shehata M. A., El-Sayed G. M., Abdel-Fattah L. E., J. AOAC Int., 89, 646-650 (2006).
23. Amin A. S., Ragab G. H., Saleh H., J. Pharm. Biomed. Anal., 30, 1347-1353 (2002).
24. Önal A., Kepekçi S. E., Öztunç A., J. AOAC Int., 88, 490-495 (2005).
25. El Walily A. F. M., Abdel Razak O., Belal S. F., Bakry R. S., J. Pharm. Biomed. Anal., 21, 1069-1076 (1999).
26. Abdel Razak O., Belal S. F., Bedair M. M., Barakat N. S., Haggag R. S., J. Pharm. Biomed. Anal., 31, 701-711 (2003).
27. Lu J., Cwik M., Kanyok T., J. Chromatogr. B., 695, 329-335 (1997).
28. Zhou M., Wei G., Liu Y., Sun Y., Xiao S., Lu L., Liu C., Zhong D., J. Chromatogr. B, 798, 43-48 (2003).
29. Perrin D. D., Dempsey B., "Buffers for pH and Metal Ion Control," Chap. 10, App. II, Wiley, New York, 1974, p. 147.
30. Saleh H. M., Al-Ghannam S. M., Alex. J. Pharm. Sci., 14, 25-29 (2000).
31. Nunno L. D., Florio S. J., J. Chem. Soc. Perkin Trans. 2, 1975, 469-1472 (1975).
32. Miyano H., Toyo'oka T., Imai K., Anal. Chim. Acta, 170, 81-87 (1985).
33. Imai K., Toyo'oka T., Miyano H., Analyst, 109, 1365-1373 (1984).
34. Conner K. A., "Reaction Mechanism in Organic Analytical Chemistry," Wiley, New York, 1973, p. 274.
35. "Guidance for Industry Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration," Center for Drug Evaluation and Research, Rockville, MD, May, 2001. http://www.fda.gov/eder/guidance/4252fnl.pdf (accessed September 1, 2004).
36. Miller J. N., Miller J. C., "Statistics and Chemometrics for Analytical Chemistry," 5th ed., Prentice Hall, England, 2005.
37. Amini H., Ahmadiani A., J. Chromatogr. B., 809, 227-230 (2004).
38. Rose J., "Advanced Physico-Chemical Experiments," Pitman, London, 1964.